
Novartis
Company Overview
Keywords
Description
Novartis is an innovative medicines company dedicated to reimagining medicine to enhance and prolong the lives of individuals worldwide. With a mission to empower patients, healthcare professionals, and societies in the fight against serious diseases, Novartis's impact is felt by over 250 million people across the globe. To learn more about Novartis and its transformative work, visit https://www.novartis.com. For information on community guidelines, visit https://go.novartis.social/3Nboxki.
Funding History
Date | Round | Amount | Lead Investors |
---|---|---|---|
Jun 19, 2024 | Post-IPO Debt | $2,487,694,394 | N/A |
Feb 14, 2018 | Grant | $6,500,000 | Bill & Melinda Gates Foundation |
Technology Stack
+1239 more technologies
Key Employees
View AllFind Executive job changes at Novartis
Frequently Asked Questions
Employee Statistics
By Seniority
Key People
Pradnesh Palav
Director - Information Security Compliance
Hyderābād, Telangāna
LinkedInTrishul Patel
Director , Precision Medicine Adv Capabilities Lead
New York City, New York
LinkedInPraveen Kumar
Senior Director Data and Ai Analytics Platform
Hyderābād
LinkedInSimilar Companies

CSL Vifor
Manufacturing
For all jobs, information and content please follow the CSL LinkedIn page.
Novartis Oncology
Manufacturing
At Novartis, our mission is to discover new ways to improve and extend people's lives. We use science-based innovation to address some of society's most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible. At Novartis, we focus on five key cancer areas where we have identified patient needs and promise within our portfolio - breast cancer, lung cancer, melanoma, kidney cancer and hematology. As a leader in oncology, Novartis offers a portfolio treating more than 25 conditions worldwide and approximately 30 compounds in development. We are passionate about what we do and the impact we have on patients and societies. We are Novartis, and we are reimagining medicine. See our community guidelines:https: https://bit.ly/3yAl483

Octapharma
Manufacturing
Headquartered in Lachen, Switzerland, Octapharma is one of the largest human protein manufacturers in the world, developing and producing human proteins from human plasma and human cell lines. Octapharma employs nearly 12,000 people worldwide to support the treatment of patients in 118 countries with products across three therapeutic areas: Immunotherapy, Haematology and Critical Care. Octapharma has seven R&D sites and five state-of-the-art manufacturing facilities in Austria, France, Germany and Sweden, and operates more than 195 plasma donation centres across Europe and the US. Octapharma has 40 years of experience in patient care. Check our community guidelines: https://bit.ly/3M8ioml